Skip to main content
SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · IEX Real-Time Price · USD
4.540
-0.070 (-1.52%)
May 17, 2024, 4:30 PM EDT - Market closed

SOPHiA GENETICS Revenue

SOPHiA GENETICS had revenue of $64.18M in the twelve months ending March 31, 2024, with 26.68% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $15.78M with 12.98% year-over-year growth. In the year 2023, SOPHiA GENETICS had annual revenue of $62.37M with 31.14% growth.

Revenue (ttm)
$64.18M
Revenue Growth
+26.68%
P/S Ratio
4.65
Revenue / Employee
$149,265
Employees
430
Market Cap
298.43M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202362.37M14.81M31.14%
Dec 31, 202247.56M7.11M17.58%
Dec 31, 202140.45M12.05M42.43%
Dec 31, 202028.40M3.04M11.98%
Dec 31, 201925.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.19B
Xeris Biopharma Holdings 171.36M
Kamada 149.55M
Poseida Therapeutics 82.50M
Caribou Biosciences 33.40M
TriSalus Life Sciences 21.98M
XOMA Corporation 5.81M
Nyxoah 5.57M
Revenue Rankings

SOPH News

More News